Opportunity Overview
Czechia – Pharmaceutical products – Medicinal products with the active ingredient OBINUTUZUMAB is a active solicitation for government procurement in Czech Republic, issued by Health and tracked by GlobalGov. It falls under Pharmaceuticals. It was published on March 11, 2026. Full solicitation details, all dates, and related live opportunities are below.
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Health |
|---|---|
| Country | Czech Republic |
| Category | Pharmaceuticals |
| Published | March 11, 2026 |
| Procurement stage | Active solicitation |
| Closed | April 10, 2026 |
| Status | Closed — no longer accepting responses |
| Translation | Translated from Hungarian by GlobalGov’s translation pipeline |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Browse Similar Open Opportunities in Czech Republic
See every Czech Republic Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free Czech Republic Pharmaceuticals intelligence report in your inbox
A personalized report on Czech Republic Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.